1264P Real-world evidence of treatment practices and therapeutic outcomes for newly diagnosed NSCLC patients with non-classical EGFR mutations demonstrates high unmet medical need.

Autor: Heymach, J.V.1 (AUTHOR), Dardenne, E.2 (AUTHOR), Liao, J.3 (AUTHOR), Guzman, C.2 (AUTHOR), Eathiraj, S.2 (AUTHOR), Zhang, N.3 (AUTHOR), Nilsson, M.1 (AUTHOR), Elamin, Y.Y.1 (AUTHOR), Le, X.1 (AUTHOR), Buck, E.2 (AUTHOR)
Zdroj: Annals of Oncology. 2024 Supplement 2, Vol. 35, pS809-S810. 2p.
Databáze: Academic Search Ultimate